Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Owning the Future of Healthcare: How Health Catalyst Drives Better Population Health Through Data

Population health may seem like a marathon, but it is immensely beneficial for patient outcomes. Jonas Varnum, Vice President of Population Health Strategic Services at Health Catalyst, joined Host Hilary Kennedy to discuss how to implement population health. The goal of population health is to create a better system with less waste. Currently, there…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Owning the Future of Healthcare: How Health Catalyst Drives Better Population Health Through Data

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Population health may seem like a marathon, but it is immensely beneficial for patient outcomes. Jonas Varnum, Vice President of Population Health Strategic Services at Health Catalyst, joined Host Hilary Kennedy to discuss how to implement population health.

The goal of population health is to create a better system with less waste. Currently, there are one trillion dollars in suboptimal care, which could be improved by 35 to 50 percent. Varied insurance models, such as commercial, Medicare, Medicaid, and others, provide a challenge in the different revenue they generate. Varnum explained, “The only real way to successfully deliver care is to have a scalable, systematic method of how you do population health across different patient populations.”

Implementation of population health means a system must answer innumerable use cases rapidly. They need to know how impactful certain patient populations are and ensure they are benchmarked appropriately. This includes examining whether utilization rates of certain services, such as emergency services and telehealth, are appropriate. Population health includes understanding patient population equity. Are patients receiving the right care at the right place and time?

Varnum explained how data is transferred to interventions such as care management, direct patient engagement, and quality measures. Health Catalyst embeds over 250 measures directly into the EHR. Clinicians can easily access them to meet specific criteria of the measures. This decreases administrative work and burnout.

Varnum’s take? “At the end of the day, what you really need to make sure that you’re doing, is understanding that after you worked that patient population, did it create outcomes?” He added, “The reality though is that if you actually have a systematic structure, then that marathon is a lot easier.”

Visit healthcatalyst.com for case studies and more information on population health or subscribe to the Owning the Future of Healthcare podcast.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512